NCT01844804 - A Pharmacokinetics Study Comparing PF-06438179 and Infliximab in Healthy Volunteers (REFLECTIONS B537-01) | Biotech Hunter

Enrollment

146

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Healthy

Interventions

BIOLOGICAL

PF-06438179

Single-dose of 10 mg/kg administered as an intravenous infusion in not less than 2 hours on Day 1

BIOLOGICAL

Remicade

Single-dose of 10 mg/kg administered as an intravenous infusion in not less than 2 hours on Day 1

BIOLOGICAL

Remicade

Single-dose of 10 mg/kg administered as an intravenous infusion in not less than 2 hours on Day 1

Trial Locations (1)

Pfizer Investigational Site, Overland Park